| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/10/2005 | US6890748 Production of lysosomal enzymes in plants by transient expression |
| 05/10/2005 | US6890746 Gene participating in the production of homo-glutamic acid and utilization thereof |
| 05/10/2005 | US6890745 For drug screening enzyme inhibitors/detecting/modulating caspase activity/apoptosis |
| 05/10/2005 | US6890744 Nucleotide sequences coding transcription factor for use in generation of lysine for use in animal nutrients the foods |
| 05/10/2005 | US6890741 Detecting preferential particles in sample; obtain sample, incubate with primers, amplify, detect amplicons, presence of amplicons indicates the presence of target particle |
| 05/10/2005 | US6890735 TSG-like gene |
| 05/10/2005 | US6890734 Nucleic acids encoding a cytokine receptor complex |
| 05/10/2005 | US6890732 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 05/10/2005 | US6890731 For drug screeing/therapy of diseases; bacteriophages |
| 05/10/2005 | US6890730 For enhanced biomass production/secretion; fusion proteins/ membranes |
| 05/10/2005 | US6890728 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components |
| 05/10/2005 | US6890726 Method for selecting recombinase variants with altered specificity |
| 05/10/2005 | US6890720 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis |
| 05/10/2005 | US6890718 Kit for the amplification and propagation of preferential nucleotide sequences |
| 05/10/2005 | US6890717 For diagnostics/screening assays/hybridization probes/primers/therapy for osteoporosis/periodontal disease |
| 05/10/2005 | US6890710 For treating influenza infections in vivo; fusion proteins; solid phase synthesis |
| 05/10/2005 | US6890709 For induction of S-phase/oncogenicity/transcription/apoptosis in cells |
| 05/10/2005 | US6890556 Controlled surface-associated delivery of genes and oligonucleotides |
| 05/10/2005 | US6890554 Genetic immunization with cationic lipids |
| 05/10/2005 | US6890538 Immunization against herpes simplex virus |
| 05/10/2005 | US6890537 Antigrowth agents; microbiocides, bactericides |
| 05/10/2005 | US6890536 Microsporidian polar tube proteins, nucleic acids coding for these proteins and their applications |
| 05/10/2005 | US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas |
| 05/10/2005 | US6890532 Postexposure prophylaxis therapy |
| 05/10/2005 | US6890531 Neuronal growth factor galectin-1 |
| 05/10/2005 | US6890528 Cells for the production of helper dependent adenoviral vectors |
| 05/10/2005 | US6890516 Identifying a substance capable of affecting long term memory in an animal comprising the determination that said substance alters activator homodimer, activator-repressor heterodimer and/ or repressor homodimer formation from normal |
| 05/10/2005 | US6889468 Modular systems and methods for using sample processing devices |
| 05/10/2005 | CA2487530A1 Method and device for targeted delivery of materials to selected single cells |
| 05/10/2005 | CA2340712C Method and device for carrying out biochemical reactions with a high throughput |
| 05/10/2005 | CA2330935C A mutant human hepatitis b viral strain and uses thereof |
| 05/10/2005 | CA2118518C Over expression of single-stranded molecules |
| 05/10/2005 | CA2067330C Herpes simplex virus type 1 mutant |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/06/2005 | WO2005040797A1 Bio-assay substrate having a power supply wire configuration |
| 05/06/2005 | WO2005040428A2 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 05/06/2005 | WO2005040426A1 Molecular marker associated with cmv resistance and use thereof |
| 05/06/2005 | WO2005040406A1 High throughput screening of antibody libraries |
| 05/06/2005 | WO2005040395A1 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 05/06/2005 | WO2005040393A1 Process for preparing enantiomer-enriched alpha-hydroxycarboxylic acids and amides |
| 05/06/2005 | WO2005040391A1 Compositions and methods for differentiating stem cells |
| 05/06/2005 | WO2005040390A1 A recombinant vaccine using yellow fever virus as vector |
| 05/06/2005 | WO2005040389A2 Compositions with chitinase activity |
| 05/06/2005 | WO2005040388A2 Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments |
| 05/06/2005 | WO2005040387A1 Site-specific intestinal delivery and/or production of biologically active substances |
| 05/06/2005 | WO2005040386A2 A vector modification for versatile use of expressed products |
| 05/06/2005 | WO2005040385A1 Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method |
| 05/06/2005 | WO2005040384A1 Minimal dna sequence acting as a chromatin insulator and its use in protein expression |
| 05/06/2005 | WO2005040383A1 B lymphoid lineage specific promoter sequences and pharmaceutical compositions containing the same |
| 05/06/2005 | WO2005040382A2 Cherkasky fusion proteins containing antibody-, antigen- and microtubule-binding regions and immune response-triggering regions |
| 05/06/2005 | WO2005040381A1 Rice and products thereof having starch with an increased proportion of amylose |
| 05/06/2005 | WO2005040380A1 Rodent immune response regulatory proteins |
| 05/06/2005 | WO2005040379A2 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/06/2005 | WO2005040378A1 Nucleic acids useful for triggering tumor cell lethality |
| 05/06/2005 | WO2005040377A2 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
| 05/06/2005 | WO2005040376A2 Method from the selection of biomolecules from biomolecule variant libraries |
| 05/06/2005 | WO2005040374A1 Method of selecting genomic dna fragment |
| 05/06/2005 | WO2005040366A1 Trans-2-enoyl-coa reductase gene of euglena gracilis |
| 05/06/2005 | WO2005040364A1 Novel recombinant animal cells with high protein production, method of constructing the same and method of mass protein production using the same |
| 05/06/2005 | WO2005040363A1 Glucosyltransferases |
| 05/06/2005 | WO2005040344A2 Generation of stabilized proteins by combinatorial consensus mutagenesis |
| 05/06/2005 | WO2005040342A2 Cleavage of rna by restriction endonucleases |
| 05/06/2005 | WO2005040340A2 Rnai-based modification of heterochromatin |
| 05/06/2005 | WO2005040339A2 Aptamers to human epidermal growth factor receptor-3 |
| 05/06/2005 | WO2005040336A2 Dna cloning vector plasmids and methods for their use |
| 05/06/2005 | WO2005040333A2 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/06/2005 | WO2005040220A1 Multispecific deimmunized cd3-binders |
| 05/06/2005 | WO2005040213A1 MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES |
| 05/06/2005 | WO2005040212A2 Orthogonal gene switches |
| 05/06/2005 | WO2005040210A2 Novel cxcl8 antagonists |
| 05/06/2005 | WO2005040209A1 Human chemokine hcc-1 polypeptides to improve stem cell transplantation |
| 05/06/2005 | WO2005040206A1 Glurp-msp3 fusion protein, immunogenic compositions and malarial vaccines containing it |
| 05/06/2005 | WO2005040204A1 A tumor-inhibiting protein and the use thereof |
| 05/06/2005 | WO2005040203A2 Msp-3-like family of genes |
| 05/06/2005 | WO2005040188A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | WO2005040187A2 The use of sirna silencing in the prevention of metastasis |
| 05/06/2005 | WO2005040186A2 Method for preparing a modified host cell |
| 05/06/2005 | WO2005040180A2 Antisense modulation of superoxide dismutase 1, soluble (sod-1) expression |
| 05/06/2005 | WO2005039645A2 Sp1 and sp3 targeted cancer therapies and therapeutics |
| 05/06/2005 | WO2005039643A2 In vivo gene therapy of parkinson's disease |
| 05/06/2005 | WO2005039642A1 Dna delivery with gemini cationic surfactants |
| 05/06/2005 | WO2005039633A1 Agent for treating leishmania infections |
| 05/06/2005 | WO2005039632A1 Colorectal cancer antigen |
| 05/06/2005 | WO2005039615A1 Use of caspase-8 inhibitors for modulating hematopoiesis |
| 05/06/2005 | WO2005039291A2 Methods, compositions and devices for inducing stasis in cells |
| 05/06/2005 | WO2005039282A1 Drosophila transgenic animal models for the treatment of human genetic diseases caused by expansions of microsatellites which contain the trinucleotide ctg |
| 05/06/2005 | WO2005039281A1 Genetically modified organisms and uses thereof |
| 05/06/2005 | WO2005039275A2 Methods for increasing the frequency of apomixis expression in angiosperms |
| 05/06/2005 | WO2005028680A3 Methods, compositions, and kits for the concentration and detection of microorganisms |
| 05/06/2005 | WO2005026314A3 Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| 05/06/2005 | WO2005019454A8 Novel rat calcium channel subunits and related probes, cell lines and methods |
| 05/06/2005 | WO2005019449A3 Expression of a recombinant transgene |
| 05/06/2005 | WO2005019448A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 05/06/2005 | WO2005014807A3 Moss expressing promoting regions |
| 05/06/2005 | WO2005010146A3 Adenoviral e1a/e1b complementing cell line |
| 05/06/2005 | WO2005004592A3 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 05/06/2005 | WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 05/06/2005 | WO2004112727A3 Aav virions with decreased immunoreactivity and uses therefor |
| 05/06/2005 | WO2004111245A3 Gdc-2 genes conferring herbicide resistance |
| 05/06/2005 | WO2004110345A8 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |